Figure 1: Year wise isolation rate of Candida spp

Figure 2: Year wise distribution of C. albicans and NAC spp

Figure 3: Species wise distribution of NAC isolates

Figure 4: Fluconazole susceptibility pattern of Candida spp by disc diffusion method

Figure 5: The year wise distribution of fluconazole resistance in Candida spp

Clinical specimen
CI (%)
CII (%)
CIII (%)
CIV (%)
CV (%)
CVI (%)
CVII (%)
CVIII (%)
CIX (%)
CX (%)
Total
Urine
169 (42.8)
98 (24.8)
63 (15.9)
24 (6.1)
21 (5.3)
6 (1.5)
10 (2.5)
-
-
4 (1.1)
395
Vaginal swabs
142 (41.2)
63 (18.2)
82 (23.8)
26 (7.5)
18 (5.3)
-
-
8 (2.6)
-
5 (1.4)
344
Oropharyngeal swabs
90 (43.2)
51 (24.5)
26 (12.4)
12 (5.5)
3 (1.4)
-
-
23 (11.1)
-
4 (1.9)
209
Blood
22 (22.4)
24 (24.5)
15 (15.3)
8 (8.2)
-
6 (6.1)
5 (5.2)
-
12 (12.2)
6 (6.1)
98
Pus
8 (53.3)
4 (26.7)
2 (13.3)
-
1 (6.7)
-
-
-
-
-
15
Miscellaneous
27 (38.6)
11 (15.8)
10 (14.4)
8 (11.4)
4 (5.7)
4 (5.7)
6 (8.7)
-
-
-
70
Total
458 (40.5)
251 (22.2)
198 (17.5)
78 (6.9)
47 (4.1)
16 (1.4)
21 (1.8)
31 (2.7)
12 (1.2)
19 (1.7)
1131

† CI: C. albicans; CII: C. tropicalis; CIII: C. glabrata; CIV: C. krusei; CV: C. kefyr; CVI: C. lusitaniae; CVII: C. parapsilosis; CVIII: C. dubliniensis; CIX: C. rugosa; CX: C. guilliermondii
†† Miscellaneous samples included various types of tips, ear swab, pleural fluid, sputum, drain fluid
Table 1: Clinical specimen wise distribution of Candida isolates

NAC spp. (n)
No. of resistant isolates (%)
C. tropicalis (251)
86 (34.3)
C. glabrata (198)
98 (49.5)
C. krusei (78)
76 (97.3)
C. kefyr (47)
12 (25.5)
C. parapsilosis (21)
04 (19.1)
C. lusitaniae (16)
02 (12.5)
C. dubliniensis (31)
09 (29.1)
C. rugosa (12)
04 (33.3)
C. guilliermondii (19)
02 (12.5)
Total (673)
293 (43.5)

Table 2: Fluconazole resistance pattern in NAC spp. by disc diffusion method